Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample.

The quantitative comparison of protein abundances across a large number of biological or patient samples represents an important proteomics challenge that needs to be addressed for proteomics discovery applications. Herein, we describe a strategy that incorporates a stable isotope (18)O-labeled "universal" reference sample as a comprehensive set of internal standards for analyzing large sample sets quantitatively. As a pooled sample, the (18)O-labeled "universal" reference sample is spiked into each individually processed unlabeled biological sample and the peptide/protein abundances are quantified based on (16)O/(18)O isotopic peptide pair abundance ratios that compare each unlabeled sample to the identical reference sample. This approach also allows for the direct application of label-free quantitation across the sample set simultaneously along with the labeling-approach (i.e., dual-quantitation) since each biological sample is unlabeled except for the labeled reference sample that is used as internal standards. The effectiveness of this approach for large-scale quantitative proteomics is demonstrated by its application to a set of 18 plasma samples from severe burn patients. When immunoaffinity depletion and cysteinyl-peptide enrichment-based fractionation with high resolution LC-MS measurements were combined, a total of 312 plasma proteins were confidently identified and quantified with a minimum of two unique peptides per protein. The isotope labeling data was directly compared with the label-free (16)O-MS intensity data extracted from the same data sets. The results showed that the (18)O reference-based labeling approach had significantly better quantitative precision compared to the label-free approach. The relative abundance differences determined by the two approaches also displayed strong correlation, illustrating the complementary nature of the two quantitative methods. The simplicity of including the (18)O-reference for accurate quantitation makes this strategy especially attractive when a large number of biological samples are involved in a study where label-free quantitation may be problematic, for example, due to issues associated with instrument platform robustness. The approach will also be useful for more effectively discovering subtle abundance changes in broad systems biology studies.

[1]  Navdeep Jaitly,et al.  DAnTE: a statistical tool for quantitative analysis of -omics data , 2008, Bioinform..

[2]  Jens Nielsen,et al.  Characterization of global yeast quantitative proteome data generated from the wild-type and glucose repression saccharomyces cerevisiae strains: the comparison of two quantitative methods. , 2008, Journal of proteome research.

[3]  Navdeep Jaitly,et al.  VIPER: an advanced software package to support high-throughput LC-MS peptide identification , 2007, Bioinform..

[4]  S. Ruben,et al.  Reproducibility assessment of relative quantitation strategies for LC-MS based proteomics. , 2007, Analytical chemistry.

[5]  Vladislav A Petyuk,et al.  Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry. , 2007, Genome research.

[6]  H. R. Bergen,et al.  A Method for Automatically Interpreting Mass Spectra of 18O-Labeled Isotopic Clusters*S , 2007, Molecular & Cellular Proteomics.

[7]  Ronald J. Moore,et al.  Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[8]  Moyez Dharsee,et al.  Differential analysis of membrane proteins in mouse fore- and hindbrain using a label-free approach. , 2006, Journal of proteome research.

[9]  Richard D. Smith,et al.  Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. , 2006, Analytical chemistry.

[10]  Ronald G. Tompkins,et al.  High Dynamic Range Characterization of the Trauma Patient Plasma Proteome*S , 2006, Molecular & Cellular Proteomics.

[11]  Jacob D. Jaffe,et al.  PEPPeR, a Platform for Experimental Proteomic Pattern Recognition*S , 2006, Molecular & Cellular Proteomics.

[12]  Richard D. Smith,et al.  Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.

[13]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[14]  Richard D. Smith,et al.  Advances in proteomics data analysis and display using an accurate mass and time tag approach. , 2006, Mass spectrometry reviews.

[15]  Guanghui Wang,et al.  Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes. , 2006, Journal of proteome research.

[16]  Stephen J. Callister,et al.  Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. , 2006, Journal of proteome research.

[17]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[18]  D. Lauffenburger,et al.  Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S , 2005, Molecular & Cellular Proteomics.

[19]  Tsuyoshi Tabata,et al.  Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards , 2005, Nature Biotechnology.

[20]  Ronald J Moore,et al.  Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach*S , 2005, Molecular & Cellular Proteomics.

[21]  T. Colgan,et al.  Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. , 2005, Journal of proteome research.

[22]  Gordon A Anderson,et al.  High-throughput comparative proteome analysis using a quantitative cysteinyl-peptide enrichment technology. , 2004, Analytical chemistry.

[23]  Richard D. Smith,et al.  High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry , 2004, Expert review of proteomics.

[24]  Ronald J Moore,et al.  An automated high performance capillary liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometer for high-throughput proteomics , 2004, Journal of the American Society for Mass Spectrometry.

[25]  R. Simon,et al.  Evaluation of normalization methods for microarray data , 2003, BMC Bioinform..

[26]  T. Shaler,et al.  Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. , 2003, Analytical chemistry.

[27]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[28]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[29]  X. Yao,et al.  Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. , 2001, Analytical chemistry.

[30]  T. Veenstra,et al.  Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. , 2001, Analytical chemistry.

[31]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[32]  Nikola Tolić,et al.  High throughput proteome-wide precision measurements of protein expression using mass spectrometry , 1999 .

[33]  F. Cross,et al.  Accurate quantitation of protein expression and site-specific phosphorylation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Thuluvath,et al.  Disease proteomics , 2009, Genomic Medicine.

[35]  Howard Schulman,et al.  Protein biomarker identification in the CSF of patients with CNS lymphoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.